No registrations found.
ID
NL-OMON22628
Source
Nationaal Trial Register
Brief title
Limberg Trial
Intervention
Outcome measures
Primary outcome
Tijd tot volledige wondgenezing
Secondary outcome
Het aantal wondinfecties, het recidiefpercentage binnen 1 jaar, en een aantal factoren die de morbiditeit na de operatie bepalen zullen worden onderzocht.
Study design
n.v.t.
Intervention
Limbergplastiek vs. sluiten in midline na excisie sinus pilonidalis
Public
Medisch Spectrum Twente
Postbus 50000
A. Stam
Enschede 7500 KA
The Netherlands
researchbureau.heelkunde@ziekenhuis-mst.nl
Postbus 50000
A. Stam
Enschede 7500 KA
The Netherlands
researchbureau.heelkunde@ziekenhuis-mst.nl
Scientific
Medisch Spectrum Twente
Postbus 50000
A. Stam
Enschede 7500 KA
The Netherlands
researchbureau.heelkunde@ziekenhuis-mst.nl
Postbus 50000
A. Stam
Enschede 7500 KA
The Netherlands
researchbureau.heelkunde@ziekenhuis-mst.nl
Inclusion criteria
primary or recurrent pilonidal sinus
width of fistulacomplex between 1 and 3 centimeter
signed informed consent
age: >/= 18 years
mentally competent
Exclusion criteria
patients with an actual abscess
not able to follow-up
patients in which woundhealing problems are to be expected (Diabetes type II, immunesupression, chemotherapy, HIV/AIDS)
not mentally competent
dementia
Design
Study type
:
Interventional
Intervention model
:
Parallel
Allocation
:
Randomized controlled trial
Masking
:
Single blinded (masking used)
Control
:
Active
Recruitment
NL
Recruitment status
:
Pending
Start date (anticipated)
:
Enrollment
:
74
Type
:
Anticipated
Not applicable
Application type
:
Not applicable
Followed up by the following (possibly more current) registration
ID: 44556
Bron: ToetsingOnlineOther (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL4792 |
| NTR-old | NTR4932 |
| CCMO | NL49989.044.14 |
| OMON | NL-OMON44556 |